Finally, focusing on C9orf72 silencing, pre-clinical testing of an AAV5-miRNA-C9ORF72 vector sponsored by UniCure showed marked reduction of C9orf72 transcripts in ALS mouse models (Martier et al., 2019). The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.